Detalles de la búsqueda
1.
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.
Curr Atheroscler Rep
; 24(7): 585-597, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35524914
2.
Gastrointestinal adverse events with insulin glargine/lixisenatide fixed-ratio combination versus glucagon-like peptide-1 receptor agonists in people with type 2 diabetes mellitus: A network meta-analysis.
Diabetes Obes Metab
; 23(1): 136-146, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32991041
3.
Effectiveness of premixed insulin to achieve glycaemic control in type 2 diabetes: A retrospective UK cohort study.
Diabetes Obes Metab
; 23(4): 929-937, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33319424
4.
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial.
Diabetes Obes Metab
; 23(6): 1221-1231, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33606908
5.
Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data.
Pharmacoepidemiol Drug Saf
; 30(7): 918-926, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33899314
6.
Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparison.
Diabetes Obes Metab
; 22(11): 2170-2178, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32627297
7.
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis.
Diabetes Obes Metab
; 22(11): 2179-2188, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32700442
8.
Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan-L trial.
Diabetes Obes Metab
; 21(12): 2712-2717, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31423722
9.
Response to letter to the editor regarding "Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data".
Pharmacoepidemiol Drug Saf
; 31(1): 110-111, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34687257
10.
Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review.
Clin Ther
; 45(11): 1119-1126, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37690915
11.
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline.
BMJ Open Diabetes Res Care
; 10(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35042751
12.
Utility of dilation and curettage in the diagnosis of pregnancy of unknown location.
Am J Obstet Gynecol
; 204(2): 130.e1-6, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21284966
13.
Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis.
Front Cardiovasc Med
; 8: 774418, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34966797
14.
Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK.
Diabetes Ther
; 11(8): 1873-1881, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32533547
15.
Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real-world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN).
Endocrinol Diabetes Metab
; 3(1): e00094, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31922021
16.
Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study.
Diabetes Ther
; 10(5): 1847-1858, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31321748
17.
Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis.
Endocrinol Diabetes Metab
; 2(3): e00061, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31294079
18.
Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA.
Diabetes Ther
; 9(3): 1347-1358, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29600507
19.
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study.
Diabetes Ther
; 8(2): 321-334, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28155131
20.
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom.
Diabetes Ther
; 8(2): 335-353, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28236271